Literature DB >> 8435636

"Economic relevance" in pharmacoeconomic studies.

J A Sacristán, J Hernández, J Soto.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8435636      PMCID: PMC1676654          DOI: 10.1136/bmj.306.6870.147-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Authors:  I S Udvarhelyi; G A Colditz; A Rai; A M Epstein
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

2.  Use and misuse of the term "cost effective" in medicine.

Authors:  P Doubilet; M C Weinstein; B J McNeil
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245

Review 3.  Clinical economics. A guide to the economic analysis of clinical practices.

Authors:  J M Eisenberg
Journal:  JAMA       Date:  1989-11-24       Impact factor: 56.272

Review 4.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

  4 in total
  2 in total

1.  Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature.

Authors:  K E Agro; C A Bradley; N Mittmann; M Iskedjian; A L Ilersich; T R Einarson
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

2.  Use of confidence intervals in health economic studies.

Authors:  J A Sacristán
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.